-
1
-
-
70349558437
-
Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1
-
In: Swerdlow SH, Campo E, Harris NL, editors. World Health Organization (WHO) Classification of Tumors. . Lyon:IARC Press;. pp-.
-
Bain BJ, Gilliland DG, Horny HP, et al. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. In: Swerdlow SH, Campo E, Harris NL, et al., editors. World Health Organization (WHO) Classification of Tumors. Pathology and Genetics. Tumors of Haematopoietic and Lymphoid Tissues. Lyon:IARC Press;2008. pp68-73.
-
(2008)
Pathology and Genetics. Tumors of Haematopoietic and Lymphoid Tissues
, pp. 68-73
-
-
Bain, B.J.1
Gilliland, D.G.2
Horny, H.P.3
-
3
-
-
0028869005
-
A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: A review
-
Macdonald D, Aguiar RC, Mason PJ, et al. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: A review. Leukemia 1995;9:1628-1630.
-
(1995)
Leukemia
, vol.9
, pp. 1628-1630
-
-
Macdonald, D.1
Aguiar, R.C.2
Mason, P.J.3
-
5
-
-
77950443181
-
Chromosome 8p11.2 translocations: Prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution
-
Patnaik MM, Gangat N, Knudson RA, et al. Chromosome 8p11.2 translocations: Prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution. Am J Hematol 2010;85:238-242.
-
(2010)
Am J Hematol
, vol.85
, pp. 238-242
-
-
Patnaik, M.M.1
Gangat, N.2
Knudson, R.A.3
-
6
-
-
0034661925
-
ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain
-
Xiao S, McCarthy JG, Aster JC, Fletcher JA. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain. Blood 2000;96:699-704.
-
(2000)
Blood
, vol.96
, pp. 699-704
-
-
Xiao, S.1
McCarthy, J.G.2
Aster, J.C.3
Fletcher, J.A.4
-
7
-
-
77957016485
-
Translocation t(3;8;9) (p25;p21;q34) in a patient with features of 8p11 myeloproliferative syndrome: A unique case and review of the literature
-
Post GR, Holloman D, Christiansen L, et al. Translocation t(3;8;9) (p25;p21;q34) in a patient with features of 8p11 myeloproliferative syndrome: A unique case and review of the literature. Leuk Res 2010;34:1543-1544.
-
(2010)
Leuk Res
, vol.34
, pp. 1543-1544
-
-
Post, G.R.1
Holloman, D.2
Christiansen, L.3
-
8
-
-
84155195286
-
A novel t(1;8)(q25;p11.2) translocation associated with 8p11 myeloproliferative syndrome
-
Yoshida C, Takeuchi M, Sadahira Y. A novel t(1;8)(q25;p11.2) translocation associated with 8p11 myeloproliferative syndrome. Br J Haematol 2012;156:271-273.
-
(2012)
Br J Haematol
, vol.156
, pp. 271-273
-
-
Yoshida, C.1
Takeuchi, M.2
Sadahira, Y.3
-
9
-
-
79958051808
-
The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)
-
Wasag B, Lierman E, Meeus P, et al. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11). Haematologica 2011;96:922-926.
-
(2011)
Haematologica
, vol.96
, pp. 922-926
-
-
Wasag, B.1
Lierman, E.2
Meeus, P.3
-
10
-
-
1642421743
-
Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations
-
Roumiantsev S, Krause DS, Neumann CA, et al. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. Cancer Cell 2004;5:287-298.
-
(2004)
Cancer Cell
, vol.5
, pp. 287-298
-
-
Roumiantsev, S.1
Krause, D.S.2
Neumann, C.A.3
-
11
-
-
11044238012
-
Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: Two further cases
-
Vizmanos JL, Hernandez R, Vidal MJ, et al. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: Two further cases. Hematol J 2004;5:534-537.
-
(2004)
Hematol J
, vol.5
, pp. 534-537
-
-
Vizmanos, J.L.1
Hernandez, R.2
Vidal, M.J.3
-
12
-
-
61549132662
-
Mastocytosis
-
In: Swerdlow SH, Campo E, Harris NL, editors. World Health Organization (WHO) Classification of Tumors. . Lyon:IARC Press;. pp-.
-
Horny HP, Akin C, Metcalfe DD, et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, et al., editors. World Health Organization (WHO) Classification of Tumors. Pathology and Genetics. Tumors of Haematopoietic and Lymphoid Tissues. Lyon:IARC Press;2008. pp54-63.
-
(2008)
Pathology and Genetics. Tumors of Haematopoietic and Lymphoid Tissues
, pp. 54-63
-
-
Horny, H.P.1
Akin, C.2
Metcalfe, D.D.3
-
14
-
-
10744228486
-
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
-
Pardanani A, Ketterling RP, Brockman SR, et al. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood 2003;102:3093-3096.
-
(2003)
Blood
, vol.102
, pp. 3093-3096
-
-
Pardanani, A.1
Ketterling, R.P.2
Brockman, S.R.3
-
15
-
-
1842579440
-
A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib
-
Akin C, Fumo G, Akif S, et al. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 2004;103:3222-3225.
-
(2004)
Blood
, vol.103
, pp. 3222-3225
-
-
Akin, C.1
Fumo, G.2
Akif, S.3
-
16
-
-
33947543336
-
Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene
-
Walz C, Metzgeroth G, Haferlach C, et al. Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene. Haematologica 2007;92:163-169.
-
(2007)
Haematologica
, vol.92
, pp. 163-169
-
-
Walz, C.1
Metzgeroth, G.2
Haferlach, C.3
-
17
-
-
0023066812
-
Mast cell disease followed by leukemia with clonal evolution
-
Lewis JP, Welborn JL, Meyers FJ, et al. Mast cell disease followed by leukemia with clonal evolution. Leuk Res 1987;11:769-773.
-
(1987)
Leuk Res
, vol.11
, pp. 769-773
-
-
Lewis, J.P.1
Welborn, J.L.2
Meyers, F.J.3
-
18
-
-
84855957112
-
Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene
-
Mayeur-Rousse C, Sorel N, Voldoire M, et al. Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene. Leuk Res 2012;36:377-381.
-
(2012)
Leuk Res
, vol.36
, pp. 377-381
-
-
Mayeur-Rousse, C.1
Sorel, N.2
Voldoire, M.3
-
19
-
-
79960426955
-
World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management
-
Gotlib J. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Am J Hematol 2011;86:677-688.
-
(2011)
Am J Hematol
, vol.86
, pp. 677-688
-
-
Gotlib, J.1
-
20
-
-
5144234541
-
PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder
-
Chen J, Deangelo DJ, Kutok JL, et al. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci USA 2004;101:14479-14484.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 14479-14484
-
-
Chen, J.1
Deangelo, D.J.2
Kutok, J.L.3
-
21
-
-
0031860817
-
Cytogenetic response induced by interferon alpha in the myeloproliferative disorder with eosinophilia, T cell lymphoma and the chromosomal translocation t(8;13)(p11;q12)
-
Martinez-Climent JA, Vizcarra E, Benet I, et al. Cytogenetic response induced by interferon alpha in the myeloproliferative disorder with eosinophilia, T cell lymphoma and the chromosomal translocation t(8;13)(p11;q12). Leukemia 1998;12:999-1000.
-
(1998)
Leukemia
, vol.12
, pp. 999-1000
-
-
Martinez-Climent, J.A.1
Vizcarra, E.2
Benet, I.3
-
22
-
-
77957019372
-
Complete molecular remission after interferon alpha treatment in a case of 8p11 myeloproliferative syndrome
-
Zhou L, Fu W, Yuan Z, Hou J. Complete molecular remission after interferon alpha treatment in a case of 8p11 myeloproliferative syndrome. Leuk Res 2010;34:e306-e307.
-
(2010)
Leuk Res
, vol.34
-
-
Zhou, L.1
Fu, W.2
Yuan, Z.3
Hou, J.4
|